Skip to content

Clinical trials

Phase 2 Cytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cytopenia Phase: Phase 2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20081
20091
20121
20132
20142
20201
20211
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Children's Hospital Medical Center, Cincinnati2
M.D. Anderson Cancer Center2
Novartis Pharmaceuticals2
Groupe Francophone des Myelodysplasies1
H. Lee Moffitt Cancer Center and Research Institute1
Kirsten Grønbæk1
Memorial Sloan Kettering Cancer Center1
Red de Terapia Celular1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cytopenia17
Myelodysplastic Syndromes8
Anemia4
Thrombocytopenia4
Anemia, Refractory, with Excess of Blasts3
Leukemia, Myeloid, Acute2
Neutropenia2
Acquired Immunodeficiency Syndrome1
Anemia, Aplastic1
Bone Marrow Diseases1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.